PTC Therapeutics | Lngresos Netos





Lngresos Netos Cambio Fecha
Acadia Pharmaceuticals USD 71.78M 45.11M 2025-09
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amgen USD 1.33B 1.88B 2025-12
BioCryst Pharmaceuticals USD -88.88M 74.85M 2024-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Cytokinetics USD -306.18M 171.81M 2025-09
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Esperion Therapeutics USD -29.52M 32.4M 2024-09
Gilead Sciences USD 2.18B 869M 2025-12
Incyte USD 299.28M 124.89M 2025-12
Ionis Pharmaceuticals USD -128.61M 252.16M 2025-09
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Novartis USD 3.93B 96M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD 15.9M 80.75M 2025-09
Puma Biotechnology USD 20.32M 24.85M 2024-09
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
TG Therapeutics USD 390.9M 362.71M 2025-09
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12
Xencor USD -6.03M 24.8M 2025-09


PTC Therapeutics Lngresos Netos - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.